The phrase "amenable to combination" is correct and usable in written English.
It can be used when discussing something that is open to being combined or integrated with other elements or ideas.
Example: "The new software is amenable to combination with existing systems, allowing for greater flexibility in operations."
Alternatives: "open to integration" or "receptive to merging".
He says the co-op has been amenable to combinations and to selling public hallway space to individual owners.
Although in this study, Cetuximab has not been used along with Sirolimus, we believe that Nimotuzumab is more amenable to this combination because of its inherent lower toxicity.
For this treatment-resistant population, among whom approximately one-third had not received MTX and thus was less amenable to responding versus combination therapy [ 15], this was not necessarily expected.
Considering that this compound may be amenable to clinical trials in combination with other anticancer agents, combinations of sapacitabine with several anticancer agents commonly used in practice, such as gemcitabine, oxaliplatin, doxorubicin, docetaxel and seliciclib, a novel CDK inhibitor (McClue et al, 2002; Meijer and Raymond, 2003), were also explored.
Thus, Y16 and rhosin were considered amenable to being used in combination.
Given that most of the Cdc42 inhibitors mentioned earlier act upon different molecular targets and via differing mechanisms, it will be interesting to see whether they are amenable to safe use in combination and whether therapeutic potency can thereby be increased.
Such a strategy, while powerful for identifying individual lead compounds, is currently not amenable to identifying potentially valuable combinations that are central to the treatment of tuberculosis.
Zebrafish are particularly amenable to multigenetic analysis through a combination of convenient microinjections of morpholinos and mRNA or cDNA.
The IGF-1/FGF-2 combisamenable amenable to generate an in vitro graft material for preclinical assays in large mammalian animal models for cartilage repair.
The EQ-5D data were obtained from GRID, a randomized, double-blind, placebo-controlled, multicenter, crossover phase III study originally designed to evaluate the efficacy and safety of regorafenib in subjects with histologically proven metastatic or unresectable gastrointestinal stromal tumor not amenable to surgery, radiation, or a combination of different approaches with curative intent.
Using alternative statistical strategies that are more amenable to the analysis of larger combinations of markers, multiple machine learning algorithms likewise showed that the novel biomarkers improved upon the diagnostic performance of the traditional biomarkers (Aβ42, tau, p-tau181).
